Catalyst Wire Dossier Catalyst Wire Dossier

Trimethobenzamide hydrochloride

Trimethobenzamide hydrochloride · Lupin Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Trimethobenzamide hydrochloride, covering 2015-01-14 to 2023-11-21. Get the full timeline:

Most recent: FDA Approved: TRIMETHOBENZAMIDE HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

See pricing